NMRA (STOCKS)
Neumora Therapeutics, Inc. Common Stock
$3.143700
+0.143700 (+4.79%)
Prev close: $3.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Paul L. Berns
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $543.88M
- Employees
- 95
- P/E (TTM)
- -2.22
- P/B (TTM)
- 3.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.32 | $-0.34 | +0.0204 | +5.99% |
|
Jun 2025 (Q2)
|
$-0.33 | $-0.38 | +0.0457 | +12.16% |
|
Mar 2025 (Q1)
|
$-0.42 | $-0.38 | -0.0382 | -10.01% |
|
Dec 2024 (Q4)
|
$-0.37 | $-0.46 | +0.0852 | +18.72% |
Financial Statements
| Assets | $177.83M |
| Current Assets | $177.08M |
| Noncurrent Assets | $751.00K |
| Fixed Assets | $80.00K |
| Other Non-current Assets | $671.00K |
| Liabilities | $45.67M |
| Current Liabilities | $25.84M |
| Accounts Payable | $549.00K |
| Wages | $8.86M |
| Other Current Liabilities | $16.44M |
| Noncurrent Liabilities | $19.83M |
| Long-term Debt | $19.56M |
| Other Non-current Liabilities | $267.00K |
| Equity | $132.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $132.16M |
| Liabilities And Equity | $177.83M |